|
AU766826B2
(en)
*
|
1998-07-30 |
2003-10-23 |
Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The |
Thymosin beta4 promotes wound repair
|
|
US6372494B1
(en)
|
1999-05-14 |
2002-04-16 |
Advanced Tissue Sciences, Inc. |
Methods of making conditioned cell culture medium compositions
|
|
KR20090115984A
(ko)
*
|
2001-11-09 |
2009-11-10 |
아르테셀 사이언스, 인크. |
지방 조직에서 유래된 기질세포의 내분비 췌장 분화 및 이의 용도
|
|
JP2007509989A
(ja)
*
|
2003-10-31 |
2007-04-19 |
ポイント バイオメディカル コーポレイション |
超音波造影剤として有用な再構成可能なミクロスフィア組成物
|
|
US20060165667A1
(en)
|
2004-12-03 |
2006-07-27 |
Case Western Reserve University |
Novel methods, compositions and devices for inducing neovascularization
|
|
US20060222634A1
(en)
|
2005-03-31 |
2006-10-05 |
Clarke Diana L |
Amnion-derived cell compositions, methods of making and uses thereof
|
|
WO2008020815A1
(en)
|
2006-08-15 |
2008-02-21 |
Agency For Science, Technology And Research |
Mesenchymal stem cell conditioned medium
|
|
US8871198B2
(en)
|
2006-03-29 |
2014-10-28 |
Stemnion, Inc. |
Methods related to wound healing
|
|
JP2009526858A
(ja)
|
2006-02-15 |
2009-07-23 |
ティカ レーケメデル アーベー |
コルチコステロイド溶液を製造する方法
|
|
WO2008024996A2
(en)
|
2006-08-24 |
2008-02-28 |
Johnstone Brian H |
Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith
|
|
US20090054339A1
(en)
|
2007-08-22 |
2009-02-26 |
Marshall Vivienne S |
Novel cellular factor-containing solution compositions
|
|
WO2009045359A1
(en)
|
2007-10-01 |
2009-04-09 |
Stemnion, Inc. |
Skin replacement compositions and methods
|
|
EP2254586B1
(en)
|
2008-02-22 |
2015-04-08 |
Agency For Science, Technology And Research (A*star) |
Mesenchymal stem cell particles
|
|
US20110256110A1
(en)
*
|
2008-10-24 |
2011-10-20 |
Children's Hospital Los Angeles |
Amniotic fluid cells and uses thereof
|
|
US20110158958A1
(en)
|
2009-12-07 |
2011-06-30 |
Sing George L |
Methods for treating ophthalmic disorders, diseases and injuries
|
|
WO2010110768A1
(en)
|
2009-03-23 |
2010-09-30 |
Regenetech, Inc. |
Composition and method for producing composition for constructing tissue, and tissue construct
|
|
DK2451964T3
(en)
|
2009-07-10 |
2018-04-30 |
Histogen Inc |
Conditioned medium and extracellular matrix compositions from cells grown under hypoxic conditions
|
|
US20110206647A1
(en)
|
2010-02-25 |
2011-08-25 |
Abt Holding Company |
Modulation of Angiogenesis
|
|
WO2011127090A1
(en)
|
2010-04-05 |
2011-10-13 |
Medstar Health Research Institute, Inc. |
Conditioned medium obtained form stem cells and its use in therapy
|
|
FR2974201B1
(fr)
|
2011-04-18 |
2013-04-12 |
Inside Secure |
Circuit de multiplication de montgomery
|
|
US20120276215A1
(en)
|
2011-04-26 |
2012-11-01 |
Riordan Neil H |
Therapeutic Conditioned Media
|
|
EP2723364A1
(en)
|
2011-06-24 |
2014-04-30 |
National University of Ireland Galway |
Cell secreted proteins for the treatment of myocardial infarction
|
|
ES2661587T3
(es)
*
|
2011-08-10 |
2018-04-02 |
Depuy Synthes Products Llc |
Tratamiento de enfermedad vascular periférica usando células derivadas de tejido del cordón umbilical
|
|
ITTO20111183A1
(it)
|
2011-12-21 |
2013-06-22 |
Univ Degli Studi Torino |
Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia
|
|
HK1202581A1
(en)
|
2012-02-13 |
2015-10-02 |
Gamida-Cell Ltd. |
Mesenchymal stem cells conditioned medium and methods of generating and using the same
|
|
ITTO20120859A1
(it)
|
2012-10-02 |
2014-04-03 |
Univ Degli Studi Torino |
Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
|
|
EP2943069B1
(en)
|
2013-01-09 |
2018-08-15 |
United Therapeutics Corporation |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
|
US20140242043A1
(en)
|
2013-02-23 |
2014-08-28 |
Stemnion, Inc. |
Methods for preventing or treating optic neuritis
|
|
US20140255355A1
(en)
|
2013-03-07 |
2014-09-11 |
Stemnion, Inc. |
Methods for treating blepharitis
|
|
CA2924562A1
(en)
|
2013-10-17 |
2015-04-23 |
Sentiss Pharma Private Limited |
Preservative-free ophthalmic pharmaceutical formulation
|
|
CL2013003066A1
(es)
|
2013-10-22 |
2014-07-25 |
Univ Chile |
Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
|
|
US9636364B2
(en)
|
2013-12-04 |
2017-05-02 |
Stemnion, Inc. |
Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
|
|
US9464272B2
(en)
|
2013-12-12 |
2016-10-11 |
Stemnion, Inc. |
Cell-derived composition
|
|
US20150335712A1
(en)
|
2014-05-21 |
2015-11-26 |
Stemnion, Inc. |
Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
|
|
WO2016082882A1
(en)
|
2014-11-27 |
2016-06-02 |
Med Cell Europe Ag |
Secretomes and method for producing secretomes
|
|
EP3224348B1
(en)
|
2014-11-27 |
2021-07-14 |
Med Cell Bahamas Ltd. |
Secretomes and method for producing secretomes
|
|
US20160158293A1
(en)
*
|
2014-12-05 |
2016-06-09 |
Janssen Biotech, Inc. |
Treatment of Ocular Conditions Using Progenitor Cells
|
|
US20170080033A1
(en)
|
2014-12-16 |
2017-03-23 |
Janssen Biotech, Inc. |
Treatment of retinal degeneration using progenitor cells
|
|
US20180327713A1
(en)
|
2014-12-16 |
2018-11-15 |
Janssen Biotech, Inc. |
Treatment of retinal degeneration using progenitor cells
|
|
SG11201704668PA
(en)
|
2014-12-16 |
2017-07-28 |
Janssen Biotech Inc |
Treatment of retinal degeneration using progenitor cells
|
|
KR101566450B1
(ko)
|
2015-04-03 |
2015-11-05 |
(유)스템메디케어 |
중간엽 줄기세포에서 단백질의 대량 생산 방법
|
|
TWI741980B
(zh)
|
2015-04-07 |
2021-10-11 |
大陸商四川藍光英諾生物科技股份有限公司 |
一種生物磚及其用途
|
|
US20160361253A1
(en)
|
2015-06-13 |
2016-12-15 |
Noveome Biotherapeutics, Inc. |
Novel Methods for Delivering Therapeutic Agents to the Eye via Nasal Passages
|
|
EP3317397B1
(en)
|
2015-07-02 |
2019-09-25 |
Med Cell Bahamas Ltd. |
Secretomes and method for producing secretomes
|
|
EP3328413B1
(en)
|
2015-07-29 |
2024-09-04 |
Indiana University Research and Technology Corporation |
Materials and methods for treating and evaluating ischemic and/or reperfusion-injured tissue and/or tissue susceptible to same
|
|
US20190046576A1
(en)
|
2016-02-12 |
2019-02-14 |
Cell Care Therapeutics |
Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same
|
|
KR20170111057A
(ko)
|
2016-03-25 |
2017-10-12 |
(주)안트로젠 |
면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
|
|
RU2708329C2
(ru)
|
2016-05-31 |
2019-12-05 |
Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" |
Материал стволовых клеток, композиции и способы применения
|
|
WO2017217967A1
(en)
|
2016-06-13 |
2017-12-21 |
Noveome Biotherapeutics, Inc. |
Novel methods for delivering therapeutic agents to the eye via nasal passages
|
|
US20180028570A1
(en)
|
2016-08-01 |
2018-02-01 |
Ucl Business Plc |
Angiogenic Factors
|
|
KR20180024223A
(ko)
|
2016-08-29 |
2018-03-08 |
사회복지법인 삼성생명공익재단 |
중간엽 줄기세포 분비 단백질을 포함하는 말초신경 세포 증식 촉진용 조성물
|
|
US20190231694A1
(en)
|
2016-10-12 |
2019-08-01 |
Agency For Science, Technology And Research |
Method for lyophilising an exosome
|
|
IT201600109148A1
(it)
*
|
2016-10-28 |
2018-04-28 |
Pharmaexceed Srl |
Processo per isolare e liofilizzare vescicole extracellulari
|
|
WO2018102174A1
(en)
|
2016-12-01 |
2018-06-07 |
Janssen Biotech, Inc. |
Treatment of retinal degeneration using progenitor cells
|
|
JP2020505345A
(ja)
|
2017-01-16 |
2020-02-20 |
セルズ フォー セルズ エセ．アー． |
乏血小板血漿（ｐｐｐ）に封入された実質的に純粋な多能性間質細胞集団を含む組成物
|
|
US20180271914A1
(en)
|
2017-03-21 |
2018-09-27 |
Noveome Biotherapeutics, Inc. |
Methods for Reducing the Extent of Light-induced Tissue Inflammation and Injury
|
|
EP3624731A4
(en)
|
2017-05-18 |
2021-02-24 |
The Board of Trustees of the Leland Stanford Junior University |
TARGETED IN-SITU THERAPEUTIC ADMINISTRATION OF SECRETED FACTORS FROM STEM CELLS FOR THE TREATMENT OF DAMAGED TISSUE
|
|
EP3655525A4
(en)
|
2017-07-16 |
2021-04-21 |
Ramot at Tel-Aviv University Ltd. |
STEM CELL SECRETOME FROM HUMAN MUCCOUS
|
|
US10364270B2
(en)
|
2017-10-02 |
2019-07-30 |
Pro Sunfun Biotech Research And Developmment Co., Ltd. |
Eye-care peptide, its composition and method of using the same
|
|
CN108517002A
(zh)
|
2018-04-20 |
2018-09-11 |
命之本源医疗科技（北京）有限公司 |
一种干细胞培养上清分泌蛋白的稳定剂
|
|
EP3801028A4
(en)
|
2018-05-30 |
2022-04-13 |
Direct Biologics LLC |
A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
|
|
TWI834808B
(zh)
|
2019-02-19 |
2024-03-11 |
西班牙商薩爾瓦特實驗室有限公司 |
以單劑包裝的克氯黴唑液體組成物
|
|
US10881693B2
(en)
|
2019-04-09 |
2021-01-05 |
Combangio, Inc. |
Processes for making and using a mesenchymal stem cell derived secretome
|
|
US12213995B2
(en)
|
2019-07-18 |
2025-02-04 |
Direct Biologics, Llc |
Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
|
|
WO2021207282A2
(en)
|
2020-04-07 |
2021-10-14 |
Combangio, Inc. |
Lyophilized mesenchymal stem cell derived secretome and uses thereof
|
|
KR20250044282A
(ko)
|
2022-07-08 |
2025-03-31 |
컴반지오, 인크. |
분비체 활성 분석을 위한 방법 및 검정
|